{"id":"https://openalex.org/W7204996004","doi":"https://doi.org/10.1158/2326-6066.c.8687961","title":"Data from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFN\u03b3 Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity","display_name":"Data from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFN\u03b3 Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity","publication_year":2026,"publication_date":"2026-09-02","ids":{"openalex":"https://openalex.org/W7204996004","doi":"https://doi.org/10.1158/2326-6066.c.8687961"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.8687961","doi":"https://doi.org/10.1158/2326-6066.c.8687961","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.8687961","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.c.8687961","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5149096046","display_name":"Daisuke Ehara","orcid":"https://orcid.org/0009-0003-0105-2996","observed_orcids":["https://orcid.org/0009-0003-0105-2996"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daisuke Ehara","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-0105-2996","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140012208","display_name":"Kiyoshi Yasui","orcid":"https://orcid.org/0000-0002-7572-7445","observed_orcids":["https://orcid.org/0000-0002-7572-7445"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kiyoshi Yasui","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7572-7445","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005612688","display_name":"Mitsuhiro Yoneda","orcid":"https://orcid.org/0000-0001-6340-1205","observed_orcids":["https://orcid.org/0000-0001-6340-1205"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitsuhiro Yoneda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6340-1205","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046810336","display_name":"Daisuke Muraoka","orcid":"https://orcid.org/0000-0002-4493-7052","observed_orcids":["https://orcid.org/0000-0002-4493-7052"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daisuke Muraoka","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4493-7052","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149090973","display_name":"Situo Deng","orcid":"https://orcid.org/0009-0000-9481-4715","observed_orcids":["https://orcid.org/0009-0000-9481-4715"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Situo Deng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-9481-4715","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149018963","display_name":"Pengyu Miao","orcid":"https://orcid.org/0009-0004-2924-4524","observed_orcids":["https://orcid.org/0009-0004-2924-4524"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pengyu Miao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-2924-4524","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140018209","display_name":"Chenxu Jiang","orcid":"https://orcid.org/0009-0000-0370-8635","observed_orcids":["https://orcid.org/0009-0000-0370-8635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chenxu Jiang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-0370-8635","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149072325","display_name":"Huimin Sun","orcid":"https://orcid.org/0009-0005-6643-5247","observed_orcids":["https://orcid.org/0009-0005-6643-5247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huimin Sun","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-6643-5247","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020638934","display_name":"Sachiko Okamoto","orcid":"https://orcid.org/0009-0005-4483-3826","observed_orcids":["https://orcid.org/0009-0005-4483-3826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sachiko Okamoto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-4483-3826","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007284232","display_name":"Yasunori Amaishi","orcid":"https://orcid.org/0009-0007-7713-6888","observed_orcids":["https://orcid.org/0009-0007-7713-6888"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasunori Amaishi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-7713-6888","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087617455","display_name":"Hiroyuki Murota","orcid":"https://orcid.org/0000-0002-0450-1377","observed_orcids":["https://orcid.org/0000-0002-0450-1377"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroyuki Murota","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0450-1377","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000192888","display_name":"Hiroaki Ikeda","orcid":"https://orcid.org/0000-0002-8012-4796","observed_orcids":["https://orcid.org/0000-0002-8012-4796"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroaki Ikeda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8012-4796","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.017100000753998756,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ferroptosis","display_name":"ferroptosis","score":1.0},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7720000147819519},{"id":"https://openalex.org/keywords/rsl3","display_name":"RSL3","score":0.7570000290870667},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.7379999756813049},{"id":"https://openalex.org/keywords/system-xc","display_name":"system xc-","score":0.8349999785423279},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6520000100135803},{"id":"https://openalex.org/keywords/t-cell-receptor-engineered-t-cells","display_name":"T cell receptor-engineered T cells","score":0.8339999914169312},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/lipid-peroxidation","display_name":"lipid peroxidation","score":0.6830000281333923},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7355999946594238},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7146999835968018},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5995000004768372},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.5990999937057495},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5401999950408936},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4726000130176544},{"id":"https://openalex.org/C2225953","wikidata":"https://www.wikidata.org/wiki/Q1661899","display_name":"Inducer","level":3,"score":0.46720001101493835},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42969998717308044},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4147999882698059},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.38019999861717224},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.375},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.36820000410079956},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.36719998717308044},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.36579999327659607},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33480000495910645},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.32429999113082886},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.310699999332428},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.29319998621940613},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28870001435279846},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.27000001072883606},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26759999990463257},{"id":"https://openalex.org/C2780635560","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Neoplasm","level":2,"score":0.2533000111579895}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.8687961","doi":"https://doi.org/10.1158/2326-6066.c.8687961","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.8687961","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.8687961","doi":"https://doi.org/10.1158/2326-6066.c.8687961","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.8687961","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7167276891","https://openalex.org/W7205015983","https://openalex.org/W7204991564","https://openalex.org/W7205000848","https://openalex.org/W7205009444","https://openalex.org/W7204990428","https://openalex.org/W7204990419","https://openalex.org/W7204996734","https://openalex.org/W7205011048","https://openalex.org/W7205000611"],"abstract_inverted_index":{"Abstract":[0],"Tumor":[1],"masses":[2],"often":[3],"exhibit":[4],"heterogeneity,":[5],"including":[6],"escape":[7],"variant":[8],"clones":[9],"that":[10,52,71,90,135],"lack":[11],"antigen-presenting":[12],"machinery":[13],"and/or":[14],"tumor":[15,46,86,105,148],"antigens,":[16],"which":[17],"poses":[18],"a":[19,25,93,103,124,151],"major":[20],"challenge":[21],"to":[22,39],"immunotherapy.":[23],"Ferroptosis,":[24],"form":[26],"of":[27,57,64,108],"regulated":[28],"cell":[29,42],"death":[30,43],"driven":[31],"by":[32,146],"iron-dependent":[33],"lipid":[34],"peroxidation,":[35],"has":[36],"been":[37],"shown":[38],"effectively":[40],"induce":[41],"in":[44],"various":[45],"cells.":[47,87],"Recent":[48],"studies":[49],"have":[50],"reported":[51],"IFN\u03b3":[53],"suppresses":[54],"the":[55,62,143],"expression":[56],"system":[58],"Xc\u2212,":[59],"thereby":[60],"enhancing":[61],"induction":[63],"ferroptosis.":[65],"Based":[66],"on":[67],"this,":[68],"we":[69],"hypothesized":[70],"combining":[72,91],"immunotherapy":[73,140],"with":[74,96,130,139],"ferroptosis":[75,94,137],"inducers":[76,138],"could":[77,141],"enhance":[78],"antitumor":[79,126],"effects":[80],"against":[81,128],"both":[82],"antigen-positive":[83],"and":[84,112],"antigen-negative":[85],"We":[88],"found":[89],"RSL3,":[92],"inducer,":[95],"MART-1\u2013specific":[97],"T-cell":[98],"receptor\u2013engineered":[99],"T":[100],"cells":[101,111],"eradicates":[102],"heterogeneous":[104],"model":[106],"consisting":[107],"human":[109],"melanoma":[110],"their":[113],"\u03b22-microglobulin":[114],"knockout":[115],"counterparts.":[116],"In":[117],"NOD.Cg-PrkdcscidIl2rgtm1Sug/ShiJic":[118],"mice,":[119],"this":[120],"combination":[121],"therapy":[122],"demonstrates":[123],"significant":[125],"effect":[127],"tumors":[129],"heterogeneity.":[131],"These":[132],"findings":[133],"suggest":[134],"integrating":[136],"overcome":[142],"limitations":[144],"imposed":[145],"escape-variant":[147],"clones,":[149],"offering":[150],"promising":[152],"strategy":[153],"for":[154],"cancer":[155],"treatment.":[156]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-09-02T00:00:00"}